1,029 results on '"Correa-Rotter, Ricardo"'
Search Results
2. First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting
3. Mind the gap in kidney care: translating what we know into what we do
4. Long-term effects of hypercalcemia in kidney transplant recipients with persistent hyperparathyroidism
5. Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex
6. New and emerging therapies for diabetic kidney disease
7. Baseline, Early Changes, and Residual Albuminuria: Post-hoc Analysis of a Clinical Trial of Dapagliflozin in Chronic Kidney Disease
8. Association of Vitamin D Receptor Polymorphisms with Osteoporosis in Mexican Postmenopausal Women
9. Dietary inflammatory index and lower glomerular filtration rate in Mexican adults
10. Projecting the clinical burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study
11. Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease
12. Association between soft drinks intake and low glomerular filtration rate in Mexican adults: Results from RenMex
13. Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria
14. Projecting the Population Level Burden of CKD Progression According to Urine Albumin-to-Creatinine Ratio Categories
15. Representation of Low- and Middle-Income Countries in CKD Drug Trials: A Systematic Review
16. Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis
17. Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials
18. Validation of an equation for free calcium estimation: accuracy improves after adjustment for phosphate and CO2
19. How to Prepare a Chronic Kidney Disease Patient for Dialysis
20. Mind the Gap in Kidney Care: Translating What We Know into What We Do
21. Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
22. Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure
23. Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions
24. The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists
25. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
26. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
27. The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis
28. #294 Pragmatic literature reviews to populate a patient-level model to project the future clinical burden of CKD in low-and middle-income countries
29. #255 PaCE CKD: the impact of caregiving on health states and work productivity in chronic kidney disease: results from an international survey
30. #254 PaCE CKD: examining health status and financial burden in patients with chronic kidney disease: assessing the non-clinical burden of disease
31. WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY
32. WCN24-1464 MEASUREMENT OF CEREBRAL BLOOD FLOW USING TRANSCRANIAL DOPPLER ULTRASOUND: COMPARISON OF TWO POPULATIONS OF PATIENTS IN CHRONIC HEMODIALYSIS
33. WCN24-890 INSIDE CKD - PRAGMATIC LITERATURE REVIEWS TO POPULATE A PATIENT-LEVEL MODEL TO PROJECT THE FUTURE CLINICAL BURDEN OF CKD IN FOUR LOW- AND MIDDLE INCOME COUNTRIES
34. WCN24-1229 EFFECTS OF TREATMENT AND CLINICAL EVENTS ON QUALITY OF LIFE IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A PRESPECIFIED ANALYSIS OF THE DAPA-CKD TRIAL
35. Frequency of Intradialytic Hypotension Events Do Not Increase with Oral Nutritional Supplementation during Hemodialysis Treatment: A Randomized Controlled Trial
36. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
37. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial
38. Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure
39. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
40. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
41. Ambient heat exposure and kidney function in patients with chronic kidney disease:a post-hoc analysis of the DAPA-CKD trial
42. Dapagliflozin in chronic kidney disease:cost-effectiveness beyond the DAPA-CKD trial
43. Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria
44. Efficacy and Safety of Dapagliflozin in Patients with Chronic Kidney Disease across the Spectrum of Frailty
45. 423.9: The First 52 Global Kidney Exchange Transplants: Overcoming Multiple Barriers to Transplantation
46. Correction of anemia by dapagliflozin in patients with type 2 diabetes
47. Mind the Gap in Kidney Care: Translating What We Know Into What We Do.
48. Conservative and Palliative Care in Old Age Individuals with End-Stage Renal Disease
49. Global Disparities in Chronic Kidney Disease Clinical Trials: A Systematic Review
50. Prevalence of thyroid dysfunction in healthy adults according to the estimated iodine intake in 24-hour urine samples: The SALMEX cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.